重庆医科大学分子医学与肿瘤研究中心,重庆,400016
网络首发:2020-09-11,
纸质出版:2020
移动端阅览
苟茜, 许琳婉, 刘智敏. 甲状腺乳头状癌雌激素受体β表达及其 5′非翻译区甲基化[J]. 中山大学学报(医学科学版), 2020,41(5).
GOU Xi, XU Lin-wan, LIU Zhi-min. ERβ Expression and Methylation of 5′-Untranslated Region in Papillary Thyroid Carcinoma[J]. Journal of Sun Yat-sen University (Medical Sciences), 2020, 41(5).
【目的】研究甲状腺乳头状癌(PTC)中雌激素受体β基因(ERβ)表达及 5′非翻译区甲基化状态,探讨ERβ在 PTC 中低表达的原因。【方法】应用 Western blot 和免疫组织化学染色法检测正常甲状腺细胞Nthy-ori3-1、PTC 细胞 BCPAP 以及正常甲状腺组织、甲状腺结节性增生组织和 PTC 组织ERβ蛋白表达;应用 qRT-PCR 检测各细胞和组织中 ERβ mRNA(0K-1)、ERβ mRNA(0N-1)和总 ERβ mRNA 表达水平;亚硫酸氢盐测序分析各细胞和组织中 ERβ 基因启动子 0K、启动子 0N 和外显子 0N 的 CpG 岛甲基化状态;DNA 甲基化转移酶抑制剂5-aza-2′-deoxycytidine(5-aza-dC)处理 Nthy-ori3-1 细胞和 BCPAP 细胞后,qRT-PCR 检测 ERβ mRNA(0K-1)、ERβ mRNA(0N-1)和总 ERβ mRNA 表达水平。【结果】与正常甲状腺细胞相比,ERβ蛋白表达水平在 PTC 细胞中明显下降(P<0.01);ERβ在正常甲状腺组织、结节性增生组织和 PTC 组织中阳性表达数分别为5/10 例、3/10 例、 0,与正常甲状腺组织相比,ERβ在 PTC 组织中的蛋白表达水平显著降低(P<0.05);与正常甲状腺细胞和组织相比,ERβ mRNA(0N-1)和总 ERβ mRNA 在 PTC 中的表达水平明显降低(P<0.01),而 ERβ mRNA(0K-1)差异无统计学意义(P>0.05);ERβ基因启动子 0N 和外显子 0N 甲基化程度在 PTC 进程中逐渐增加,而启动子 0K 在常甲状腺、结节性增生和 PTC 组织和细胞中均未甲基化或低甲基化;5-aza-dC 使 BCPAP 细胞中ERβ mRNA(0N- 1)和总 ERβ mRNA 重新表达,但对 ERβ mRNA(0K-1)的表达无影响。【结论】ERβ基因 5′非翻译区甲基化使PTC 中 ERβ基因表达降低,尤其是启动子0N 和外显子 0N 异常甲基化。
【Objective】To investigate the expression of estrogen receptor beta(ERβ)and methylation status of 5′- untranslated region in papillary thyroid carcinoma(PTC)and explore the reason for the low expression of ERβ in PTC.【Methods】Western blot and immunohistochemical staining were used to analyze the protein expression of ERβ in human normal thyroid Nthy-ori3-1 cells,thyroid papillary carcinoma BCPAP cells and tissues of normal thyroid,nodular hyperplasia and PTC. qRT-PCR was employed to detect the expression levels of ERβ mRNA(0K-1),ERβ mRNA(0N-1) and total ERβ mRNA in cells and tissues. Bisulfite genomic sequencing was performed to evaluate the methylation status of CpG islands in promoter 0K,promoter 0N and exon 0N in cells and tissues. After Nthy- ori3-1 cells and BCPAP cells were treated with 5-aza-2′-deoxycytidine(5-aza-dC),a DNA methyltransferase(DNMT)inhibitor,qRT-PCR was used to examine the expression levels of ERβ mRNA(0K-1),ERβ mRNA(0N-1)and total ERβ mRNA in the treated cells.【Results】The protein expression of ERβ in PTC cells was significantly lower than that in normal thyroid cells(P<0.01). The cases with positive ER β expression in tissues of normal thyroid ,nodular hyperplasia and PTC were 5 ,3 and 0 , respectively(all n=10). The protein expression of ERβ in PTC tissues was significantly lower than that in normal thyroid tissues(P<0.05). Compared with those in normal thyroid cells and tissues,the expression levels of ERβ mRNA(0N-1) and total ERβ mRNA in PTC were significantly reduced(P<0.01),while ERβ mRNA(0K-1)expression showed no significant difference(P>0.05). The methylation degrees of ERβ promoter 0N and exon 0N were gradually increased in the development of PTC,while promoter 0K was unmethylated or hypomethylated in normal thyroid,nodular hyperplasia and PTC cells and tissues. 5-aza-dC treatment resulted in reexpression of ERβ mRNA(0N-1)and total ERβ mRNA in BCPAP cells but brought no change in ER β mRNA (0K-1) expression. 【Conclusions】Methylation in ER β 5′-untranslated region is correlated to the low expression of ERβ gene in PTC,especially aberrant methylation of promoter 0N and exon 0N.
0
浏览量
141
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621
